CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Biller Jonathan EVP and Chief Legal Officer | Sale 10b5-1 | −1,738 | $418.77 | $728K | 18,280 |
| 2024-02-12 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Sale 10b5-1 | −913 | $420.24 | $384K | 23,137 |
| 2024-02-12 | Arbuckle Stuart A EVP, COO | Sale 10b5-1 | −4,295 | $420.24 | $1.8M | 75,718 |
| 2024-02-12 | Ambrose Kristen SVP & Chief Accounting Officer | Sale 10b5-1 | −1,374 | $420.24 | $577K | 9,676 |
| 2024-02-12 | ALTSHULER DAVID EVP, Global Research and CSO | Sale 10b5-1 | −3,145 | $420.24 | $1.3M | 47,588 |
| 2024-02-09 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Shares withheld for taxes | −2,607 | $422.74 | $1.1M | 63,454 |
| 2024-02-09 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Shares withheld for taxes 10b5-1 | −2,100 | $422.74 | $888K | 68,493 |
| 2024-02-09 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes 10b5-1 | −2,022 | $422.74 | $855K | 77,586 |
| 2024-02-09 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −8,255 | $422.74 | $3.5M | 162,271 |
| 2024-02-09 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −2,100 | $422.74 | $888K | 46,810 |
| 2024-02-09 | Biller Jonathan EVP and Chief Legal Officer | Shares withheld for taxes 10b5-1 | −1,588 | $422.74 | $671K | 20,018 |
| 2024-02-09 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −832 | $422.74 | $352K | 24,050 |
| 2024-02-09 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes 10b5-1 | −3,177 | $422.74 | $1.3M | 80,013 |
| 2024-02-09 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −591 | $422.74 | $250K | 11,050 |
| 2024-02-09 | ALTSHULER DAVID EVP, Global Research and CSO | Shares withheld for taxes 10b5-1 | −2,099 | $422.74 | $887K | 50,733 |
| 2024-02-09 | LEIDEN JEFFREY M Executive Chairman | Shares withheld for taxes | −8,048 | $422.74 | $3.4M | 30,300 |
| 2024-02-08 | LEIDEN JEFFREY M Executive Chairman | Shares withheld for taxes | −2,698 | $421.73 | $1.1M | 38,348 |
| 2024-02-07 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Grant or award | +7,114 | 66,061 | ||
| 2024-02-07 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Grant or award | +7,114 | 70,593 | ||
| 2024-02-07 | Sachdev Amit EVP Chief Patient & Ext Af Off | Grant or award | +7,114 | 79,608 |
Page 24 of 27 · 524 trades